Monitoring Outcome in Neonatal Thrombocytopenia
Learn more about:
Related Access Program
Related Clinical Trial
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Monitoring Outcome in Neonatal Thrombocytopenia
Towards Routine HPA-screening In Pregnancy to Prevent FNAIT
Kinetics of Blood Platelets Transfused to Healthy Subjects
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates